Furosemide-Associated Nephrotoxicity

Mechanism and Risk Factors

High-dose furosemide administration has been associated with worsening renal function in heart failure patients, with one study showing that patients who received 60mg more furosemide had greater deterioration in renal function compared to those who received lower doses 1
Intravenous furosemide at high doses (80mg) can cause acute reduction in renal perfusion and subsequent azotemia in patients with cirrhosis and ascites 2

In heart failure patients, worsening renal function during furosemide therapy has been associated with increased mortality, with an increase in serum creatinine >0.3 mg/dL during hospitalization associated with nearly 3 times greater risk of in-hospital mortality 1
Careful titration of diuretic therapy is recommended to promote effective diuresis while avoiding worsening renal function 1
Furosemide should be used with caution and only in the case of intravascular fluid overload, as it could induce or increase hypovolemia and promote thrombosis 3, 4

In patients with severe edema, furosemide should be started at appropriate doses (0.5-2 mg/kg per dose) with adequate monitoring of fluid status, electrolytes, blood pressure, and kidney function 3
High doses of furosemide (>6 mg/kg/day) should not be given for periods longer than 1 week 3
Furosemide must be stopped in the case of anuria 3
In cirrhosis patients, intravenous furosemide can cause azotemia, and its repeated use should be minimized until its safety and efficacy are evaluated in randomized trials 2
In sepsis management, guidelines specifically state not to use furosemide unless hypervolemia, hyperkalemia, and/or renal acidosis are present 5